Executive Director and TA Head - Specialty

GSK•Upper Providence, PA

8d•Hybrid

About The Position

The Global Real-World Evidence & Health Outcomes Research Therapy Area Head will be the overall leader of the non-interventional data generation team for the specialty therapy area. Accountabilities include management and development of a team of leaders and scientists with expertise in real-world evidence and other non-interventional study methods. This role will ensure that team members engage closely with global medical teams and other matrix stakeholders and partners to plan and design data generation plans (DGPs) for priority assets in the TA, drive disciplined execution of studies and activities, translate results and disseminate data and research findings to all relevant internal and external stakeholders. The Global Real-World Evidence & Health Outcomes Research TA Head Specialty will lead the therapy area team to deliver relevant, innovative, and high impact evidence to meet the needs of external stakeholders such as health care professionals, scientific communities, Health Technology Assessment (HTA) and recommending bodies, patient and advocacy groups and other material stakeholders. The role will work with senior cross-functional leadership in medical affairs, market access, commercial, LoCs to ensure deliverables from this team are strategically aligned, transparent and timely. This role will ensure evidence generation projects conducted by this team comply with GSK SOPs and external regulatory and research standards. This role will bring together and consolidate pre-existing teams and will need a clear vision of how to structure and build these groups for the future. This includes development of NIS research capability, harnessing new and exciting innovations, optimizing resources in alignment with portfolio priorities and ensure capacity to deliver endorsed evidence generation strategies and plans. The role presents a unique opportunity to shape something new, setting a high bar in the structuring and future delivery of non-interventional research for the therapy area. This role will require active engagement with other senior leaders, external thought partners and will need to exert significant influence across a diverse range of stakeholders both internal and external. This role will provide YOU the opportunity to lead key activities to progress YOUR career.

Requirements

PhD, PharmD, MD or equivalent level qualification in a relevant scientific
Minimum Ph.D, PharmD, MBA, MD or equivalent.
8+ years of experience in Health Outcomes or evidence generation leadership position.
Other advanced scientific or business degree specialized in Health Outcomes or similar.
10 + years of experience in Health Outcomes work or similar.

Nice To Haves

Strong understanding of regulatory requirements and ethical guidelines for observational research.
Proven track record of successful team management and leadership.
Excellent analytical, communication, and presentation skills.
Ability to build and maintain effective collaborations with internal and external stakeholders.
Strong organizational and project management skills.

Responsibilities

Provide leadership, management, and development of the therapy area team, including recruitment and capability building, support, and improvement opportunities through best practice sharing to create high performing, quality assured resources which support the business.
Provide advice and guidance for best practice in evidence methodologies, including enabling external scientific advice, ensuring appropriate protocol review committee’s advice sought and incorporated.
Drive innovation across the TA, inform ideas and options through effective engagement with external experts, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment to enable more efficient evidence development for portfolio assets across the lifecycle (e.g. discovery, launching and life cycle management assets)
Facilitate alignment and remove barriers to enable more effective interactions within the complex stakeholder matrix, e.g. clinical, commercial, market access, medical affairs functions.
Negotiate with key stakeholders as to what evidence is and is not developed, weighing risks and benefits to optimize reimbursement opportunities.
Represent GSK in external collaborations, engagement and scientific evidence requirements with scientific partners, reimbursement bodies and other decision makers.
Manage the therapy area team’s budget and resources and appoint asset leads and scientists in alignment with portfolio priorities.
Enable appropriate infrastructure to gather and communicate metrics of the impact/value for the therapy area activities which can be communicated to critical audiences internally and externally as required.
Navigate diverse cultures and understand dynamics of health care systems at the country level including country wealth, payer decision making processes and priorities.